ArticleActa haematologica2024

Efficacy of Preexposure Prophylaxis with Monoclonal Antibody Tixagevimab-Cilgavimab against Emerging SARS-CoV-2 Resistant Variants in Patients with Chronic Lymphocytic Leukemia.

Ohad Benjamini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.